- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02116816
Absorption Profiles of Three Polyphenol Preparations With and Without Pollen Shell Covering
Investigation Into Polyphenol Absorption Profiles
This study consists of two parts. The first part of the study looked at the absorption of three different polyphenol preparations into the blood, the variability of their absorption and whether their absorption could be enhanced by mixing with pollen shells. For this purpose 12 healthy volunteers were recruited. All participants received all the 3 supplements with and without mixing with pollen shells so they had a total of 3 tests. For each test six blood samples were taken over an 8 hour period. Urine samples were also collected.
Oligopin was selected from the first study. The second part of study aims to look at the effects of Oligopin on endothelial function by assessing vascular tone and function in healthy volunteers using a non-invasive, direct measurement of vasodilatory capacity (EndoPAT). Nitrate and nitrite measurements, as well as blood pressure measurements, will also be recorded to provide a clear clinical assessment of the effects of this preparation (if any) upon vascular function. The effects of Oligopin will be compared to a placebo (methylcellulose-filled capsules) to allow a robust assessment of any clinical effects. A total of 24 healthy volunteers will be recruited for this study.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study consists of two parts. The first part of the study looked at the absorption of three different polyphenol preparations into the blood, the variability of their absorption and whether their absorption could be enhanced by mixing with pollen shells (pollen shells have been shown to enhance lipid molecule absorption). For this purpose 12 healthy volunteers were recruited. All participants received all the 3 supplements with and without mixing with pollen shells so they had a total of 3 tests. For each test six blood samples were taken over an 8 hour period. Urine samples were also collected.
Oligopin was selected from the first study. The second part of study aims to look at the effects of Oligopin on endothelial function by assessing vascular tone and function in healthy volunteers using a non-invasive, direct measurement of vasodilatory capacity (EndoPAT). Nitrate and nitrite measurements, as well as blood pressure measurements, will also be recorded to provide a clear clinical assessment of the effects of this preparation (if any) upon vascular function. The effects of Oligopin will be compared to a placebo (methylcellulose-filled capsules) to allow a robust assessment of any clinical effects. A total of 24 healthy volunteers will be recruited for this study.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
East Yorkshire
-
Hull, East Yorkshire, Det Forenede Kongerige, HU3 2RW
- Michael White Centre for Diabetes and Endocrinology
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Male or Female subjects between the age of 18-65 who can speak and understand English
- No concomitant medication including herbal medicines and food supplements
- No concomitant disease processes
- Body Mass Index 21- 29kg/m2
- Systolic blood pressure ≤150 mm Hg and diastolic pressure <90 mm Hg
- Subjects who have given informed consent
Exclusion Criteria:
- Patients not wishing to allow disclosure to their GPs.
- Concomitant medication including herbal medicines and food supplements
- Concomitant disease processes
- History of drug/alcohol abuse or Alcohol intake within 24 hours of dosing visit (visits 2-4)
- Body Mass Index <21 and > 29kg/m2
- Systolic blood pressure >150 mm Hg and or a diastolic pressure>90 mm Hg
- Unable to tolerate polyphenol products or adhere to low polyphenol diet
- Vegetarian
- Subjects not willing or able to fast until 12 noon (a total of 14 hours).
- Pregnant females or planning to conceive in the next 3 months.
- Participation in any other study currently or in the last three months.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Polyphenol
Polyphenol preparations
|
Polyphenol
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Area Under the Absorption Curve for each polyphenol preparation
Tidsramme: 8 hours
|
Blood samples will be withdrawn 6 times over an 8 hour period: baseline, then 30 minutes, 1 hour, 2 hours, 4 hours and 8 hours after ingestion of each polyphenol supplement (total 3 supplements)
|
8 hours
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Thozhukat Sathyapalan, MBBS FRCP MD, University of Hull
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- Protocol Version 2
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Polyphenols Absorption Profile
-
AstraZenecaIQVIA RDS (Shanghai) Co., Ltd.Afsluttet
-
Malaysia Palm Oil BoardUniversity of MalayaAfsluttet
-
Tufts UniversityAfsluttet
-
Probiotical S.p.A.University of FlorenceAfsluttet
-
Gedeon Richter Plc.AfsluttetFarmakokinetisk profilDet Forenede Kongerige
-
King's College LondonAfsluttetAbsorption; KemikalierDet Forenede Kongerige
-
Gaia Herbs Inc.Appalachian College of PharmacyAfsluttet
-
Texas Tech UniversityNutraceutical CorporationAfsluttetFarmakokinetisk analyse af næringsstofabsorption fra en ny liposomal multivitamin/mineralformuleringMineral AbsorptionForenede Stater
-
Jodi StookeyRekrutteringCaries | Metabolomisk profilForenede Stater
Kliniske forsøg med Polyphenol
-
Access Business GroupClinical Research LaboratoriesAfsluttet
-
King's College LondonLucozade Ribena SuntoryAfsluttetSunde mænd og kvinderDet Forenede Kongerige
-
Neurophenols ConsortiumLaval University; Atrium Innovations; Activ'inside; Fruit d'Or; Laboratoire NutriNeuro... og andre samarbejdspartnereAfsluttetSunde ældreFrankrig, Canada
-
Institut d'Investigació Biomèdica de BellvitgeAfsluttet
-
Technological Centre of Nutrition and Health, SpainAfsluttetGenekspression | Kardiovaskulær funktionSpanien
-
King's College LondonLucozade Ribena SuntoryAfsluttetSunde mænd og kvinderDet Forenede Kongerige
-
University of ExeterAfsluttet
-
Queen Margaret UniversityBarry CallebautAfsluttetKropsvægtDet Forenede Kongerige
-
Northumbria UniversityNaturexAfsluttetAerob kapacitetDet Forenede Kongerige
-
Ralph HamillAfsluttetHjerte-kar-sygdommeForenede Stater